The global market for Anti-infective API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-infective API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-infective API by region & country, by Type, and by Application.

The Anti-infective API market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infective API.

Market Segmentation

Scope of Anti-infective API - Market Report

Report Metric	Details
Report Name	Anti-infective API - Market
CAGR	5%
Segment by Type:	β-lactam Drugs Macrolides Carbapenems Quinolones
Segment by Application	Antibacterial Drugs for Systemic Use Antiviral Drugs for Systemic Use Antigen for Whole Body Bacteria Immune Serum and Immunoglobulin Anti-mycobacterial Drugs Vaccine Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	North China Pharmaceutical, CSPC, Harbin Pharmaceutical Group Pharmaceutical General Factory, Henan Huaxing Pharmaceutical Factory, Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical, Zhangjiakou Diha Pharmaceutical, Shandong Lukang Medicine, Zhuhai United Laboratories, Lunan Pharmaceutical Group, Sandoz
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-infective API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-infective API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-infective API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Anti-infective API - Market report?

Ans: The main players in the Anti-infective API - Market are North China Pharmaceutical, CSPC, Harbin Pharmaceutical Group Pharmaceutical General Factory, Henan Huaxing Pharmaceutical Factory, Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical, Zhangjiakou Diha Pharmaceutical, Shandong Lukang Medicine, Zhuhai United Laboratories, Lunan Pharmaceutical Group, Sandoz

What are the Application segmentation covered in the Anti-infective API - Market report?

Ans: The Applications covered in the Anti-infective API - Market report are Antibacterial Drugs for Systemic Use, Antiviral Drugs for Systemic Use, Antigen for Whole Body, Bacteria, Immune Serum and Immunoglobulin, Anti-mycobacterial Drugs, Vaccine, Other

What are the Type segmentation covered in the Anti-infective API - Market report?

Ans: The Types covered in the Anti-infective API - Market report are β-lactam Drugs, Macrolides, Carbapenems, Quinolones

1 Market Overview

1.1 Anti-infective API Product Introduction

1.2 Global Anti-infective API Market Size Forecast

1.2.1 Global Anti-infective API Sales Value (2019-2030)

1.2.2 Global Anti-infective API Sales Volume (2019-2030)

1.2.3 Global Anti-infective API Sales Price (2019-2030)

1.3 Anti-infective API Market Trends & Drivers

1.3.1 Anti-infective API Industry Trends

1.3.2 Anti-infective API Market Drivers & Opportunity

1.3.3 Anti-infective API Market Challenges

1.3.4 Anti-infective API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti-infective API Players Revenue Ranking (2023)

2.2 Global Anti-infective API Revenue by Company (2019-2024)

2.3 Global Anti-infective API Players Sales Volume Ranking (2023)

2.4 Global Anti-infective API Sales Volume by Company Players (2019-2024)

2.5 Global Anti-infective API Average Price by Company (2019-2024)

2.6 Key Manufacturers Anti-infective API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anti-infective API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anti-infective API

2.9 Anti-infective API Market Competitive Analysis

2.9.1 Anti-infective API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anti-infective API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infective API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 β-lactam Drugs

3.1.2 Macrolides

3.1.3 Carbapenems

3.1.4 Quinolones

3.2 Global Anti-infective API Sales Value by Type

3.2.1 Global Anti-infective API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anti-infective API Sales Value, by Type (2019-2030)

3.2.3 Global Anti-infective API Sales Value, by Type (%) (2019-2030)

3.3 Global Anti-infective API Sales Volume by Type

3.3.1 Global Anti-infective API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anti-infective API Sales Volume, by Type (2019-2030)

3.3.3 Global Anti-infective API Sales Volume, by Type (%) (2019-2030)

3.4 Global Anti-infective API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Antibacterial Drugs for Systemic Use

4.1.2 Antiviral Drugs for Systemic Use

4.1.3 Antigen for Whole Body

4.1.4 Bacteria

4.1.5 Immune Serum and Immunoglobulin

4.1.6 Anti-mycobacterial Drugs

4.1.7 Vaccine

4.1.8 Other

4.2 Global Anti-infective API Sales Value by Application

4.2.1 Global Anti-infective API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anti-infective API Sales Value, by Application (2019-2030)

4.2.3 Global Anti-infective API Sales Value, by Application (%) (2019-2030)

4.3 Global Anti-infective API Sales Volume by Application

4.3.1 Global Anti-infective API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anti-infective API Sales Volume, by Application (2019-2030)

4.3.3 Global Anti-infective API Sales Volume, by Application (%) (2019-2030)

4.4 Global Anti-infective API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anti-infective API Sales Value by Region

5.1.1 Global Anti-infective API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anti-infective API Sales Value by Region (2019-2024)

5.1.3 Global Anti-infective API Sales Value by Region (2025-2030)

5.1.4 Global Anti-infective API Sales Value by Region (%), (2019-2030)

5.2 Global Anti-infective API Sales Volume by Region

5.2.1 Global Anti-infective API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anti-infective API Sales Volume by Region (2019-2024)

5.2.3 Global Anti-infective API Sales Volume by Region (2025-2030)

5.2.4 Global Anti-infective API Sales Volume by Region (%), (2019-2030)

5.3 Global Anti-infective API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anti-infective API Sales Value, 2019-2030

5.4.2 North America Anti-infective API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anti-infective API Sales Value, 2019-2030

5.5.2 Europe Anti-infective API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anti-infective API Sales Value, 2019-2030

5.6.2 Asia Pacific Anti-infective API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anti-infective API Sales Value, 2019-2030

5.7.2 South America Anti-infective API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anti-infective API Sales Value, 2019-2030

5.8.2 Middle East & Africa Anti-infective API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti-infective API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anti-infective API Sales Value

6.2.1 Key Countries/Regions Anti-infective API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anti-infective API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anti-infective API Sales Value, 2019-2030

6.3.2 United States Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anti-infective API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anti-infective API Sales Value, 2019-2030

6.4.2 Europe Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anti-infective API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anti-infective API Sales Value, 2019-2030

6.5.2 China Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anti-infective API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anti-infective API Sales Value, 2019-2030

6.6.2 Japan Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anti-infective API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anti-infective API Sales Value, 2019-2030

6.7.2 South Korea Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anti-infective API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anti-infective API Sales Value, 2019-2030

6.8.2 Southeast Asia Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anti-infective API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anti-infective API Sales Value, 2019-2030

6.9.2 India Anti-infective API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anti-infective API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 North China Pharmaceutical

7.1.1 North China Pharmaceutical Company Information

7.1.2 North China Pharmaceutical Introduction and Business Overview

7.1.3 North China Pharmaceutical Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 North China Pharmaceutical Anti-infective API Product Offerings

7.1.5 North China Pharmaceutical Recent Development

7.2 CSPC

7.2.1 CSPC Company Information

7.2.2 CSPC Introduction and Business Overview

7.2.3 CSPC Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSPC Anti-infective API Product Offerings

7.2.5 CSPC Recent Development

7.3 Harbin Pharmaceutical Group Pharmaceutical General Factory

7.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Company Information

7.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Introduction and Business Overview

7.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Offerings

7.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Development

7.4 Henan Huaxing Pharmaceutical Factory

7.4.1 Henan Huaxing Pharmaceutical Factory Company Information

7.4.2 Henan Huaxing Pharmaceutical Factory Introduction and Business Overview

7.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Offerings

7.4.5 Henan Huaxing Pharmaceutical Factory Recent Development

7.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical

7.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Company Information

7.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Introduction and Business Overview

7.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Offerings

7.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Development

7.6 Zhangjiakou Diha Pharmaceutical

7.6.1 Zhangjiakou Diha Pharmaceutical Company Information

7.6.2 Zhangjiakou Diha Pharmaceutical Introduction and Business Overview

7.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Offerings

7.6.5 Zhangjiakou Diha Pharmaceutical Recent Development

7.7 Shandong Lukang Medicine

7.7.1 Shandong Lukang Medicine Company Information

7.7.2 Shandong Lukang Medicine Introduction and Business Overview

7.7.3 Shandong Lukang Medicine Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Shandong Lukang Medicine Anti-infective API Product Offerings

7.7.5 Shandong Lukang Medicine Recent Development

7.8 Zhuhai United Laboratories

7.8.1 Zhuhai United Laboratories Company Information

7.8.2 Zhuhai United Laboratories Introduction and Business Overview

7.8.3 Zhuhai United Laboratories Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Zhuhai United Laboratories Anti-infective API Product Offerings

7.8.5 Zhuhai United Laboratories Recent Development

7.9 Lunan Pharmaceutical Group

7.9.1 Lunan Pharmaceutical Group Company Information

7.9.2 Lunan Pharmaceutical Group Introduction and Business Overview

7.9.3 Lunan Pharmaceutical Group Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Lunan Pharmaceutical Group Anti-infective API Product Offerings

7.9.5 Lunan Pharmaceutical Group Recent Development

7.10 Sandoz

7.10.1 Sandoz Company Information

7.10.2 Sandoz Introduction and Business Overview

7.10.3 Sandoz Anti-infective API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Sandoz Anti-infective API Product Offerings

7.10.5 Sandoz Recent Development

8 Industry Chain Analysis

8.1 Anti-infective API Industrial Chain

8.2 Anti-infective API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anti-infective API Sales Model

8.5.2 Sales Channel

8.5.3 Anti-infective API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

North China Pharmaceutical

CSPC

Harbin Pharmaceutical Group Pharmaceutical General Factory

Henan Huaxing Pharmaceutical Factory

Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical

Zhangjiakou Diha Pharmaceutical

Shandong Lukang Medicine

Zhuhai United Laboratories

Lunan Pharmaceutical Group

Sandoz Inc

List of Tables

Table 1. Anti-infective API Market Trends

Table 2. Anti-infective API Market Drivers & Opportunity

Table 3. Anti-infective API Market Challenges

Table 4. Anti-infective API Market Restraints

Table 5. Global Anti-infective API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anti-infective API Revenue Market Share by Company (2019-2024)

Table 7. Global Anti-infective API Sales Volume by Company (2019-2024) & (Kiloton)

Table 8. Global Anti-infective API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anti-infective API Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Anti-infective API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anti-infective API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anti-infective API

Table 13. Global Anti-infective API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infective API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-infective API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anti-infective API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anti-infective API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anti-infective API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anti-infective API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anti-infective API Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)

Table 22. Global Anti-infective API Sales Volume by Type (2019-2024) & (Kiloton)

Table 23. Global Anti-infective API Sales Volume by Type (2025-2030) & (Kiloton)

Table 24. Global Anti-infective API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anti-infective API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anti-infective API Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Anti-infective API Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Anti-infective API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anti-infective API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anti-infective API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anti-infective API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anti-infective API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anti-infective API Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)

Table 34. Global Anti-infective API Sales Volume by Application (2019-2024) & (Kiloton)

Table 35. Global Anti-infective API Sales Volume by Application (2025-2030) & (Kiloton)

Table 36. Global Anti-infective API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anti-infective API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anti-infective API Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Anti-infective API Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Anti-infective API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anti-infective API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anti-infective API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anti-infective API Sales Value by Region (2019-2024) & (%)

Table 44. Global Anti-infective API Sales Value by Region (2025-2030) & (%)

Table 45. Global Anti-infective API Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030

Table 46. Global Anti-infective API Sales Volume by Region (2019-2024) & (Kiloton)

Table 47. Global Anti-infective API Sales Volume by Region (2025-2030) & (Kiloton)

Table 48. Global Anti-infective API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anti-infective API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anti-infective API Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Anti-infective API Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Anti-infective API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anti-infective API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anti-infective API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anti-infective API Sales Volume, (2019-2024) & (Kiloton)

Table 56. Key Countries/Regions Anti-infective API Sales Volume, (2025-2030) & (Kiloton)

Table 57. North China Pharmaceutical Company Information

Table 58. North China Pharmaceutical Introduction and Business Overview

Table 59. North China Pharmaceutical Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. North China Pharmaceutical Anti-infective API Product Offerings

Table 61. North China Pharmaceutical Recent Development

Table 62. CSPC Company Information

Table 63. CSPC Introduction and Business Overview

Table 64. CSPC Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. CSPC Anti-infective API Product Offerings

Table 66. CSPC Recent Development

Table 67. Harbin Pharmaceutical Group Pharmaceutical General Factory Company Information

Table 68. Harbin Pharmaceutical Group Pharmaceutical General Factory Introduction and Business Overview

Table 69. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Offerings

Table 71. Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Development

Table 72. Henan Huaxing Pharmaceutical Factory Company Information

Table 73. Henan Huaxing Pharmaceutical Factory Introduction and Business Overview

Table 74. Henan Huaxing Pharmaceutical Factory Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Henan Huaxing Pharmaceutical Factory Anti-infective API Product Offerings

Table 76. Henan Huaxing Pharmaceutical Factory Recent Development

Table 77. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Company Information

Table 78. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Introduction and Business Overview

Table 79. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Offerings

Table 81. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Development

Table 82. Zhangjiakou Diha Pharmaceutical Company Information

Table 83. Zhangjiakou Diha Pharmaceutical Introduction and Business Overview

Table 84. Zhangjiakou Diha Pharmaceutical Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Zhangjiakou Diha Pharmaceutical Anti-infective API Product Offerings

Table 86. Zhangjiakou Diha Pharmaceutical Recent Development

Table 87. Shandong Lukang Medicine Company Information

Table 88. Shandong Lukang Medicine Introduction and Business Overview

Table 89. Shandong Lukang Medicine Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Shandong Lukang Medicine Anti-infective API Product Offerings

Table 91. Shandong Lukang Medicine Recent Development

Table 92. Zhuhai United Laboratories Company Information

Table 93. Zhuhai United Laboratories Introduction and Business Overview

Table 94. Zhuhai United Laboratories Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Zhuhai United Laboratories Anti-infective API Product Offerings

Table 96. Zhuhai United Laboratories Recent Development

Table 97. Lunan Pharmaceutical Group Company Information

Table 98. Lunan Pharmaceutical Group Introduction and Business Overview

Table 99. Lunan Pharmaceutical Group Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Lunan Pharmaceutical Group Anti-infective API Product Offerings

Table 101. Lunan Pharmaceutical Group Recent Development

Table 102. Sandoz Company Information

Table 103. Sandoz Introduction and Business Overview

Table 104. Sandoz Anti-infective API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Sandoz Anti-infective API Product Offerings

Table 106. Sandoz Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Anti-infective API Downstream Customers

Table 110. Anti-infective API Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-infective API Product Picture

Figure 2. Global Anti-infective API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-infective API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anti-infective API Sales Volume (2019-2030) & (Kiloton)

Figure 5. Global Anti-infective API Sales Price (2019-2030) & (US$/Ton)

Figure 6. Anti-infective API Report Years Considered

Figure 7. Global Anti-infective API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anti-infective API Players Sales Volume Ranking (2023) & (Kiloton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-infective API Revenue in 2023

Figure 10. Anti-infective API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. β-lactam Drugs Picture

Figure 12. Macrolides Picture

Figure 13. Carbapenems Picture

Figure 14. Quinolones Picture

Figure 15. Global Anti-infective API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Anti-infective API Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Anti-infective API Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)

Figure 18. Global Anti-infective API Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Anti-infective API Price by Type (2019-2030) & (US$/Ton)

Figure 20. Product Picture of Antibacterial Drugs for Systemic Use

Figure 21. Product Picture of Antiviral Drugs for Systemic Use

Figure 22. Product Picture of Antigen for Whole Body

Figure 23. Product Picture of Bacteria

Figure 24. Product Picture of Immune Serum and Immunoglobulin

Figure 25. Product Picture of Anti-mycobacterial Drugs

Figure 26. Product Picture of Vaccine

Figure 27. Product Picture of Other

Figure 28. Global Anti-infective API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 29. Global Anti-infective API Sales Value Market Share by Application, 2023 & 2030

Figure 30. Global Anti-infective API Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)

Figure 31. Global Anti-infective API Sales Volume Market Share by Application, 2023 & 2030

Figure 32. Global Anti-infective API Price by Application (2019-2030) & (US$/Ton)

Figure 33. North America Anti-infective API Sales Value (2019-2030) & (US$ Million)

Figure 34. North America Anti-infective API Sales Value by Country (%), 2023 VS 2030

Figure 35. Europe Anti-infective API Sales Value (2019-2030) & (US$ Million)

Figure 36. Europe Anti-infective API Sales Value by Country (%), 2023 VS 2030

Figure 37. Asia Pacific Anti-infective API Sales Value (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Anti-infective API Sales Value by Country (%), 2023 VS 2030

Figure 39. South America Anti-infective API Sales Value (2019-2030) & (US$ Million)

Figure 40. South America Anti-infective API Sales Value by Country (%), 2023 VS 2030

Figure 41. Middle East & Africa Anti-infective API Sales Value (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Anti-infective API Sales Value by Country (%), 2023 VS 2030

Figure 43. Key Countries/Regions Anti-infective API Sales Value (%), (2019-2030)

Figure 44. Key Countries/Regions Anti-infective API Sales Volume (%), (2019-2030)

Figure 45. United States Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 46. United States Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 47. United States Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 48. Europe Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 49. Europe Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 50. Europe Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 51. China Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 52. China Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 53. China Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 54. Japan Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 55. Japan Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 56. Japan Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 57. South Korea Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 58. South Korea Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 59. South Korea Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 60. Southeast Asia Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 61. Southeast Asia Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 62. Southeast Asia Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 63. India Anti-infective API Sales Value, (2019-2030) & (US$ Million)

Figure 64. India Anti-infective API Sales Value by Type (%), 2023 VS 2030

Figure 65. India Anti-infective API Sales Value by Application (%), 2023 VS 2030

Figure 66. Anti-infective API Industrial Chain

Figure 67. Anti-infective API Manufacturing Cost Structure

Figure 68. Channels of Distribution (Direct Sales, and Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Infectives Market Research Report 2025

Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inhaled Anti Infectives Market Research Report 2025

Global Anti infectious Disease Drugs Market Research Report 2025

Acetaminophen API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Amphotericin B API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Imipenem API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ampicillin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immunosuppressants API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psychiatric API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Antiviral Drugs Market

Epalrestat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Miglustat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Label Printing Ink Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25S15382

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

Global Stretchable Conductive Ink Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26K15725

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

Global High Temperature Resistant Labels Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19N15811

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

Global 3D Printing Non-Metallic Materials Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23B15071

Wed Apr 23 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »